NewslettersDermal Cell News Zantrene Shows Impressive Synergy With BRAF & MEK Inhibitors In Treating Melanoma By Bob - July 4, 2022 0 Race Oncology Limited shared the final results from our preclinical melanoma research program in collaboration with the University of Newcastle [Race Oncology Ltd] Press Release